97 related articles for article (PubMed ID: 25775275)
1. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.
Georgescu MM; Yell P; Mobley BC; Shang P; Georgescu T; Wang SH; Canoll P; Hatanpaa KJ; White CL; Raisanen JM
Acta Neuropathol Commun; 2015 Mar; 3():11. PubMed ID: 25775275
[TBL] [Abstract][Full Text] [Related]
2. IIIG9 inhibition in adult ependymal cells changes adherens junctions structure and induces cellular detachment.
Baeza V; Cifuentes M; Martínez F; Ramírez E; Nualart F; Ferrada L; Oviedo MJ; De Lima I; Troncoso N; Saldivia N; Salazar K
Sci Rep; 2021 Sep; 11(1):18537. PubMed ID: 34535732
[TBL] [Abstract][Full Text] [Related]
3. Mutation profiling of anaplastic ependymoma grade III by Ion Proton next generation DNA sequencing.
Butt E; Alyami S; Nageeti T; Saeed M; AlQuthami K; Bouazzaoui A; Athar M; Abduljaleel Z; Al-Allaf F; Taher M
F1000Res; 2019; 8():613. PubMed ID: 32612806
[No Abstract] [Full Text] [Related]
4. NHERF1/EBP50 immunoexpression in renal cell carcinomas and oncocytomas with ultrastructural analysis of clear cell renal cell carcinoma.
Aksionau A; Silva RA; Hartman B; Flowers A
Transl Androl Urol; 2023 Aug; 12(8):1283-1295. PubMed ID: 37680228
[TBL] [Abstract][Full Text] [Related]
5. NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.
Bellizzi A; Malfettone A; Cardone RA; Mangia A
Breast Care (Basel); 2010; 5(2):86-90. PubMed ID: 21048827
[TBL] [Abstract][Full Text] [Related]
6. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
7. Different conformational dynamics of PDZ1 and PDZ2 in full-length EBP50 analyzed by hydrogen/deuterium exchange mass spectrometry.
Park JY; Duc NM; Kim DK; Lee SY; Li S; Seo MD; Woods VL; Chung KY
Biochem Cell Biol; 2015 Aug; 93(4):290-7. PubMed ID: 25789870
[TBL] [Abstract][Full Text] [Related]
8. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
Georgescu MM; Gagea M; Cote G
Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
[TBL] [Abstract][Full Text] [Related]
9. PDZ Protein Regulation of G Protein-Coupled Receptor Trafficking and Signaling Pathways.
Dunn HA; Ferguson SS
Mol Pharmacol; 2015 Oct; 88(4):624-39. PubMed ID: 25808930
[TBL] [Abstract][Full Text] [Related]
10. Sorting nexin 27 regulates basal and stimulated brush border trafficking of NHE3.
Singh V; Yang J; Cha B; Chen TE; Sarker R; Yin J; Avula LR; Tse M; Donowitz M
Mol Biol Cell; 2015 Jun; 26(11):2030-43. PubMed ID: 25851603
[TBL] [Abstract][Full Text] [Related]
11. Tailor-made ezrin actin binding domain to probe its interaction with actin in-vitro.
Shrivastava R; Köster D; Kalme S; Mayor S; Neerathilingam M
PLoS One; 2015; 10(4):e0123428. PubMed ID: 25860910
[TBL] [Abstract][Full Text] [Related]
12. Dissecting protein reaction dynamics in living cells by fluorescence recovery after photobleaching.
Fritzsche M; Charras G
Nat Protoc; 2015 May; 10(5):660-80. PubMed ID: 25837418
[TBL] [Abstract][Full Text] [Related]
13. SNX17 affects T cell activation by regulating TCR and integrin recycling.
Osborne DG; Piotrowski JT; Dick CJ; Zhang JS; Billadeau DD
J Immunol; 2015 May; 194(9):4555-66. PubMed ID: 25825439
[TBL] [Abstract][Full Text] [Related]
14. Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?
Olsen TK; Panagopoulos I; Meling TR; Micci F; Gorunova L; Thorsen J; Due-Tønnessen B; Scheie D; Lund-Iversen M; Krossnes B; Saxhaug C; Heim S; Brandal P
Neuro Oncol; 2015 Oct; 17(10):1365-73. PubMed ID: 25795305
[TBL] [Abstract][Full Text] [Related]
15. Spinal Ependymomas: An Updated WHO Classification and a Narrative Review.
Villanueva-Castro E; Meraz-Soto JM; Hernández-Dehesa IA; Tena-Suck ML; Hernández-Reséndiz R; Mateo-Nouel EJ; Ponce-Gómez JA; Arriada-Mendicoa JN
Cureus; 2023 Nov; 15(11):e49086. PubMed ID: 38125233
[TBL] [Abstract][Full Text] [Related]
16. Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma.
Nakagawa M; Matsumoto T; Yokoi A; Hashimura M; Oguri Y; Konno R; Ishibashi Y; Ito T; Ohhigata K; Harada Y; Fukagawa N; Kodera Y; Saegusa M
Mol Oncol; 2023 Oct; 17(10):2168-2182. PubMed ID: 37539980
[TBL] [Abstract][Full Text] [Related]
17. Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy.
Georgescu MM; Whipple SG; Notarianni CM
Cell Commun Signal; 2022 Aug; 20(1):123. PubMed ID: 35978432
[TBL] [Abstract][Full Text] [Related]
18. Ependymal Cilia: Physiology and Role in Hydrocephalus.
Ji W; Tang Z; Chen Y; Wang C; Tan C; Liao J; Tong L; Xiao G
Front Mol Neurosci; 2022; 15():927479. PubMed ID: 35903173
[TBL] [Abstract][Full Text] [Related]
19. Molecular Classification and Therapeutic Targets in Ependymoma.
Larrew T; Saway BF; Lowe SR; Olar A
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944845
[TBL] [Abstract][Full Text] [Related]
20. A Critical Role for Na
Kammala AK; Syed M; Yang C; Occhiuto CJ; Subramanian H
J Immunol; 2021 Feb; 206(3):471-480. PubMed ID: 33361207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
